I-FABP and fecal calprotectin in necrotizing enterocolitis in newborns: A prospective clinical study
- 10 December 2025
- journal article
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 3
Abstract
Objective. To evaluate the diagnostic and prognostic value of I-FABP (in serum and urine) and fecal calprotectin as biomarkers for the early diagnosis of necrotizing enterocolitis (NEC) in newborns. Materials and methods. A prospective study involving 42 newborns was conducted. The main group included 12 newborns with a confirmed NEC diagnosis. The comparison group included 18 newborns with intestinal symptoms without NEC. The control group consisted of 12 healthy newborns. The levels of I-FABP in serum and urine, as well as fecal calprotectin, were measured in all the subjects. Receiver Operating Characteristic (ROC) analysis was used to assess the diagnostic accuracy of the markers by calculating the area under the curve (AUC), sensitivity, and specificity. Results. Levels of serum I-FABP, urinary I-FABP, and fecal calprotectin in NEC patients were significantly higher than those in the comparison and control groups ( p < 0.001). ROC analysis demonstrated high diagnostic value for each biomarker: serum I-FABP – AUC = 0.91; urinary I-FABP – AUC = 0.76; fecal calprotectin – AUC = 0.86. The combination of the investigated markers showed the highest efficacy, with an AUC of 0.93, a sensitivity of 93.5%, and a specificity of 91.7%. Conclusion. Necrotizing enterocolitis is a life-threatening condition, whose early diagnosis remains challenging. The study results confirm the high informativity of I-FABP and fecal calprotectin as biomarkers of intestinal injury. The combination of these markers demonstrates exceptionally high diagnostic accuracy (sensitivity 93.5%, specificity 91.7%), supporting their use in clinical practice to improve the early diagnosis and management of NEC patients.Keywords
This publication has 9 references indexed in Scilit:
- Association between the risk of necrotizing enterocolitis and intrauterine growth: a multicenter cohort studyPediatric Research, 2025
- A time series algorithm to predict surgery in neonatal necrotizing enterocolitisBMC Medical Informatics and Decision Making, 2024
- Values of serum intestinal fatty acid-binding protein, fecal calprotectin, and fecal human β-defensin 2 for predicting necrotizing enterocolitisBMC Pediatrics, 2024
- Necrotizing enterocolitis: current understanding of the prevention and managementPediatric Surgery International, 2024
- Fecal calprotectin as a non-invasive marker for the prediction of post-necrotizing enterocolitis stricturePediatric Surgery International, 2023
- Fecal Calprotectin Levels Dynamics in Newborns with High-Risk of Necrotizing EnterocolitisPediatric pharmacology, 2023
- Protein linking fatty acids and its genetic regulation in children having food allergyPacific Medical Journal, 2022
- Bad news announcementNeonatology: News, Opinions, Training, 2022
- Characteristics of and treatment for respiratory mycoplasmosis in children during the epidemic season 2020–2021Voprosy praktičeskoj pediatrii, 2021